CD68 and neoplasm: Moreover, VISTA expression was higher in CD68+ tumor-associated macrophages (TAMs; 32.58%) than in CD4+ T cells (4.97%), CD8+ cytotoxic T cells (4.48%), or CD20+ B cells (1.46%) (Figures 4C, D).